vs
Side-by-side financial comparison of GDEV Inc. (GDEV) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.
GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $119.9M, roughly 1.3× GDEV Inc.). GDEV Inc. runs the higher net margin — 13.9% vs 6.2%, a 7.6% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 13.3%).
GDEV Inc. is a gaming and entertainment holding company. It is a publicly traded company listed on the Nasdaq stock exchange, headquartered in Limassol, Cyprus. The holding was evolved in June 2023 from a video game company Nexters, founded in 2014, one of the top five independent mobile game companies in Europe. Subsidiaries of GDEV include Nexters Studio, which operates offices in Cyprus, Armenia, and Kazakhstan, as well as Cubic Games, Royal Ark, Game Gears and Light Hour Games. The compan...
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
GDEV vs GKOS — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $119.9M | $150.6M |
| Net Profit | $16.6M | $9.4M |
| Gross Margin | — | 77.9% |
| Operating Margin | 15.5% | 9.0% |
| Net Margin | 13.9% | 6.2% |
| Revenue YoY | 13.3% | 41.2% |
| Net Profit YoY | 13.0% | — |
| EPS (diluted) | $0.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $150.6M | ||
| Q4 25 | — | $143.1M | ||
| Q3 25 | — | $133.5M | ||
| Q2 25 | $119.9M | $124.1M | ||
| Q1 25 | — | $106.7M | ||
| Q4 24 | — | $105.5M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $105.8M | $95.7M |
| Q1 26 | — | $9.4M | ||
| Q4 25 | — | $-133.7M | ||
| Q3 25 | — | $-16.2M | ||
| Q2 25 | $16.6M | $-19.7M | ||
| Q1 25 | — | $-18.1M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-21.4M | ||
| Q2 24 | $14.7M | $-50.5M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% |
| Q1 26 | — | 9.0% | ||
| Q4 25 | — | -97.7% | ||
| Q3 25 | — | -12.3% | ||
| Q2 25 | 15.5% | -18.3% | ||
| Q1 25 | — | -19.4% | ||
| Q4 24 | — | -27.2% | ||
| Q3 24 | — | -25.5% | ||
| Q2 24 | 14.4% | -31.3% |
| Q1 26 | — | 6.2% | ||
| Q4 25 | — | -93.4% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | 13.9% | -15.8% | ||
| Q1 25 | — | -17.0% | ||
| Q4 24 | — | -31.8% | ||
| Q3 24 | — | -22.1% | ||
| Q2 24 | 13.9% | -52.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.28 | ||
| Q2 25 | $0.90 | $-0.34 | ||
| Q1 25 | — | $-0.32 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.39 | ||
| Q2 24 | $0.81 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $276.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-129.4M | $670.9M |
| Total Assets | $210.2M | $893.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $276.7M | ||
| Q4 25 | — | $90.8M | ||
| Q3 25 | — | $98.2M | ||
| Q2 25 | $41.6M | $100.8M | ||
| Q1 25 | — | $114.3M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | $50.8M | $68.1M |
| Q1 26 | — | $670.9M | ||
| Q4 25 | — | $656.2M | ||
| Q3 25 | — | $769.5M | ||
| Q2 25 | $-129.4M | $765.1M | ||
| Q1 25 | — | $764.0M | ||
| Q4 24 | — | $766.9M | ||
| Q3 24 | — | $668.5M | ||
| Q2 24 | $-118.7M | $665.2M |
| Q1 26 | — | $893.3M | ||
| Q4 25 | — | $893.5M | ||
| Q3 25 | — | $999.4M | ||
| Q2 25 | $210.2M | $987.0M | ||
| Q1 25 | — | $966.2M | ||
| Q4 24 | — | $974.8M | ||
| Q3 24 | — | $926.5M | ||
| Q2 24 | $282.8M | $919.7M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.